BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nocentini A, Capasso C, Supuran CT. Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present). Expert Opin Ther Pat 2021;:1-10. [PMID: 33909515 DOI: 10.1080/13543776.2021.1923694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 das Neves GM, Kagami LP, Battastini AMO, Figueiró F, Eifler-Lima VL. Targeting ecto-5'-nucleotidase: A comprehensive review into small molecule inhibitors and expression modulators. Eur J Med Chem 2023;247:115052. [PMID: 36599229 DOI: 10.1016/j.ejmech.2022.115052] [Reference Citation Analysis]
2 Liu W, Yu X, Yuan Y, Feng Y, Wu C, Huang C, Xie P, Li S, Li X, Wang Z, Qi L, Chen Y, Shi L, Li MJ, Huang Z, Tang B, Chang A, Hao J. CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism. Adv Sci (Weinh) 2022;:e2206335. [PMID: 36563135 DOI: 10.1002/advs.202206335] [Reference Citation Analysis]
3 Jongerius C, Vermeulen L, van Egmond M, Evers AWM, Buffart LM, Lenos KJ. Behavioral factors to modulate immunotherapy efficacy in cancer. Front Immunol 2022;13:1066359. [PMID: 36591246 DOI: 10.3389/fimmu.2022.1066359] [Reference Citation Analysis]
4 Shen A, Ye Y, Chen F, Xu Y, Zhang Z, Zhao Q, Zeng Z. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.969034] [Reference Citation Analysis]
5 Schäkel L, Mirza S, Winzer R, Lopez V, Idris R, Al-Hroub H, Pelletier J, Sévigny J, Tolosa E, Müller CE. Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy. J Immunother Cancer 2022;10:e004660. [PMID: 35981785 DOI: 10.1136/jitc-2022-004660] [Reference Citation Analysis]
6 Mcdonald PC, Chafe SC, Supuran CT, Dedhar S. Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers 2022;14:3297. [DOI: 10.3390/cancers14143297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
7 Scortichini M, Idris RM, Moschütz S, Keim A, Salmaso V, Dobelmann C, Oliva P, Losenkova K, Irjala H, Vaittinen S, Sandholm J, Yegutkin GG, Sträter N, Junker A, Müller CE, Jacobson KA. Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors. J Med Chem 2022. [PMID: 35080883 DOI: 10.1021/acs.jmedchem.1c01852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bhujbal SP, Hah JM. Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach. Int J Mol Sci 2021;22:12745. [PMID: 34884548 DOI: 10.3390/ijms222312745] [Reference Citation Analysis]